Intranasal insulin in Alzheimer’s disease: Food for thought

Accumulating evidence suggests that disrupted brain insulin signaling promotes the development and progression of Alzheimer’s disease (AD), driving clinicians to target this circuitry. While both traditional and more modern antidiabetics show promise in combating insulin resistance, intranasal insul...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Colin D., Schiöth, Helgi B., Grillo, Claudia A., Benedict, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523803/
https://www.ncbi.nlm.nih.gov/pubmed/29180222
http://dx.doi.org/10.1016/j.neuropharm.2017.11.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523803/
https://www.ncbi.nlm.nih.gov/pubmed/29180222
http://dx.doi.org/10.1016/j.neuropharm.2017.11.037

Ejemplares similares